Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-105-7
CAS number: 54326-11-3
Oral administration of aluminum, benzoate
C16-18 fatty acid complexes to parental male and female rats at dose
levels of 375, 750 and 1500 mg/kg bw/day (equivalent to 56.3, 113 and
225 mg/kg bw/day) did not result in any adverse reproductive effects or
any definitive test article-related changes in the development or
survival of the offspring.
from the clinical pathology evaluations and neurobehavioral testing on
parent animals did not reveal any definitive effects that could be
attributed to treatment at the dose levels tested. In addition there
were no changes in blood chemisry and haematlogy assessments of parent
animals that were indicative of a reaction to treatment. Consequently,
in the absence of any pathological and oragn weight changes amongst the
parent animals there was no eveidence of any systemic effects at any of
the dose levels examined.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again